MEETING OVERVIEW

27th Annual Perspectives in Urology: Point Counterpoint
Scottsdale, Arizona
November 9-11, 2018

The 27th Annual Perspectives in Urology: Point Counterpoint will bring together leading experts in urology, medical oncology, and radiation oncology to discuss and debate the latest topics in men’s health, general urology, and genitourinary cancers. This annual interactive conference will offer topical lectures, pro/con debates, interesting-case presentations, interactive panel discussions, and interactive audience response technology. Topics include nocturia, advanced and M0 prostate cancer, bladder cancer and immunotherapy, upper tract cancer management, renal cell carcinoma, MRI and imaging, and other urologic topics.

The goal of PCP 27 is to address key questions on practice-changing developments in these topics, and to examine the next generation in diagnosis and treatment. The conference’s format includes not only didactic lectures, but also debates, point-counterpoint discussion panels, and unique-case presentations.

Program Director

E. DAVID CRAWFORD, MD

Professor of Surgery, Urology and Radiation Oncology
E. David Crawford Endowed Chair in Urologic Oncology
University of Colorado, Denver
Aurora, CO

Learning Objectives

  • Discuss best practices for management of urologic conditions like LUTS, ED, nocturia, prostatitis, and incontinence for improved patient care.
  • Identify the impact of testosterone on men’s health and the impact of ADT on quality of life.
  • Assess the expanded use of biomarkers to detect for bladder and prostate cancer.
  • Evaluate the recent advancements in therapeutic layering and drug sequencing in treating prostate cancer, especially in the M0 space.
  • Appraise the role of immunotherapy and checkpoint inhibition in treating genitourinary cancers.

Target Audience
This activity is designed for and will benefit urologists, medical oncologists, radiation oncologists, primary care physicians, and other healthcare professionals involved in the diagnosis and management of urologic diseases.

CME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Medical College of Wisconsin and Carden Jennings Publishing. The Medical College of Wisconsin is accredited with commendation by the ACCME to provide continuing medical education for physicians.

Credit Designation
MCW designates this live activity for a maximum of 17.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Of Conflicts Of Interest
It is the policy of the Medical College of Wisconsin to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, the MCW identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of the activity. Conflicts are resolved by MCW to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.

Presentations from Previous Meetings